Logo image of XELB

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

NASDAQ:XELB - Nasdaq - US98400M2008 - Common Stock - Currency: USD

1.59  -0.02 (-1.24%)

After market: 1.58 -0.01 (-0.63%)

Fundamental Rating

2

Taking everything into account, XELB scores 2 out of 10 in our fundamental rating. XELB was compared to 122 industry peers in the Specialty Retail industry. XELB has a bad profitability rating. Also its financial health evaluation is rather negative. XELB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XELB has reported negative net income.
XELB had a negative operating cash flow in the past year.
In the past 5 years XELB always reported negative net income.
XELB had negative operating cash flow in 4 of the past 5 years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

XELB's Return On Assets of -36.01% is on the low side compared to the rest of the industry. XELB is outperformed by 91.80% of its industry peers.
XELB has a Return On Equity of -68.14%. This is in the lower half of the industry: XELB underperforms 74.59% of its industry peers.
Industry RankSector Rank
ROA -36.01%
ROE -68.14%
ROIC N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 105.50%, XELB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
XELB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for XELB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 105.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
XELB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XELB has been reduced compared to 5 years ago.
XELB has a worse debt/assets ratio than last year.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

XELB has an Altman-Z score of -2.57. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
XELB has a worse Altman-Z score (-2.57) than 87.70% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that XELB is not too dependend on debt financing.
XELB's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. XELB outperforms 57.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -2.57
ROIC/WACCN/A
WACC10.51%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

XELB has a Current Ratio of 0.28. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
XELB's Current ratio of 0.28 is on the low side compared to the rest of the industry. XELB is outperformed by 96.72% of its industry peers.
A Quick Ratio of 0.28 indicates that XELB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.28, XELB is doing worse than 76.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

XELB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.44%, which is quite impressive.
The Revenue for XELB has decreased by -46.68% in the past year. This is quite bad
XELB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.67% yearly.
EPS 1Y (TTM)65.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.56%
Revenue 1Y (TTM)-46.68%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-39.01%

3.2 Future

XELB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.75% yearly.
XELB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.96% yearly.
EPS Next Y49.22%
EPS Next 2Y51.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.09%
Revenue Next 2Y30.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 2.29, the valuation of XELB can be described as very cheap.
99.18% of the companies in the same industry are more expensive than XELB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, XELB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.29
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XELB's earnings are expected to grow with 51.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.75%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XELB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCEL BRANDS INC

NASDAQ:XELB (7/17/2025, 6:31:46 PM)

After market: 1.58 -0.01 (-0.63%)

1.59

-0.02 (-1.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners20.05%
Inst Owner Change0%
Ins Owners39.33%
Ins Owner Change3.44%
Market Cap3.85M
Analysts82.86
Price Target13.77 (766.04%)
Short Float %6.37%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.7%
Min EPS beat(2)-3.39%
Max EPS beat(2)28.79%
EPS beat(4)3
Avg EPS beat(4)41.98%
Min EPS beat(4)-3.39%
Max EPS beat(4)87.75%
EPS beat(8)7
Avg EPS beat(8)37.54%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-40.41%
Min Revenue beat(2)-43.05%
Max Revenue beat(2)-37.78%
Revenue beat(4)1
Avg Revenue beat(4)-21.19%
Min Revenue beat(4)-43.05%
Max Revenue beat(4)7.72%
Revenue beat(8)2
Avg Revenue beat(8)-11.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-22.86%
PT rev (3m)-28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-900%
EPS NY rev (1m)0%
EPS NY rev (3m)-128%
Revenue NQ rev (1m)-27.66%
Revenue NQ rev (3m)-38.78%
Revenue NY rev (1m)-32.02%
Revenue NY rev (3m)-34.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.29
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.97
EYN/A
EPS(NY)0.69
Fwd EY43.62%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS3.06
BVpS11.46
TBVpS-2.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.01%
ROE -68.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 105.5%
FCFM N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -2.57
F-Score3
WACC10.51%
ROIC/WACCN/A
Cap/Depr(3y)2.47%
Cap/Depr(5y)7.52%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.56%
EPS Next Y49.22%
EPS Next 2Y51.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-46.68%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-39.01%
Revenue Next Year12.09%
Revenue Next 2Y30.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.16%
OCF growth 3YN/A
OCF growth 5YN/A